Blood Cancer Journal - Table of Contents alert Volume 2 April 2012

TABLE OF CONTENTS Volume 2, April 2012 In this issue Review Original Articles Letter to the Editor Sign up for e-alerts Web feed Advertisement 90 page eBook --- download now for free! Published in January 2012 Key Advances in Medicine summarizes the key clinical studies published in 2011 and highlights the trends to watch for in 2012. The perfect resource for busy medical students, physicians, and clinical researchers who want to catch up with the medical literature from 2011. Don't miss out!   Review Top Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies N K El-Mallawany, J K Frazer, P Van Vlierberghe, A A Ferrando, S Perkins, M Lim, Y Chu and M S Cairo Blood Cancer J 2012 2: e65; 10.1038/bcj.2012.8 Abstract | Full Text Original Articles Top Anti-tumor activity against multiple myeloma by combination of KW-2478, an Hsp90 inhibitor, with bortezomib T Ishii, T Seike, T Nakashima, S Juliger, L Maharaj, S Soga, S Akinaga, J Cavenagh, S Joel and Y Shiotsu Blood Cancer J 2012 2: e68; 10.1038/bcj.2012.13 Abstract | Full Text Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo T Kiziltepe, J D Ashley, J F Stefanick, Y M Qi, N J Alves, M W Handlogten, M A Suckow, R M Navari and B Bilgicer Blood Cancer J 2012 2: e64; 10.1038/bcj.2012.10 Abstract | Full Text Potent antitumor effects of bevacizumab in a microenvironment-dependent human lymphoma mouse model F Mori, T Ishida, A Ito, F Sato, A Masaki, H Takino, M Ri, S Kusumoto, H Komatsu, R Ueda, H Inagaki and S Iida Blood Cancer J 2012 2: e67; 10.1038/bcj.2012.12 Abstract | Full Text Letter to the Editor Top Clonal evolution in UKE-1 cell line leading to an increase in JAK2 copy number C Buors, N Douet-Guilbert, F Morel, L Lecucq, B Cassinat and V Ugo Blood Cancer J 2012 2: e66; 10.1038/bcj.2012.11 Full Text Advertisement Blood Cancer Journal now indexed by Thomson Reuters ISI We are pleased to inform you that Blood Cancer Journal has been selected for coverage in Thomson Reuter’s products and services and will be indexed and abstracted in: - Science Citation Index Expanded (also known as SciSearch®) - Journal Citation Reports/Science Edition - Current Contents®/Clinical Medicine - Biological Abstracts - BIOSIS Previews   You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.